Aspirin-Myocardial Infarction Study (AMIS)

• Status: Completed
• Trial end date: 1979-08-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine whether the daily administration of 1 gm of aspirin to individuals with a documented myocardial infarction would result in a significant reduction in mortality over a three year period.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Aspirin

Criteria

Men and women, ages 30 to 69. Had a documented myocardial infarction.